]>
IRCT2015111713940N2 IRCT 2016-04-26 Vice President of Research Shiraz University of Medical Sciences effect vitex and sage on osteogenic factors and physical and emotional symptoms in menopausal women comparison of Panjangosht and Maryamgoli effects on the osteogenic factors and physical and On the consideration and comparison of Panjangosht (Vitex agnus-castus) and Maryamgoli (Salvia officinalis) effects on the osteogenic factors and physical and emotional symptoms in menopausal women 2016-04-20 anticipated 100 Complete https://irct.ir/trial/13656 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Block permutation methods. N/A Condition 1: -. Condition 2: -. Intervention 1: the first intervention group is given, daily, one Agnugol tablets, 3.2- 4.8 Mg for 3 monthes( product Goldarou Company of Esfahan). Intervention 2: the second intervention group is given, daily, three Salvigol tablets, 100 Mg for 3 monthes ( product of Goldarou Company of Esfahan). Intervention 3: In control group is given each daily three placebo tablets for 3 monthes.
public marzieh akbarzadeh
Namazi Square, Shiraz
shiraz Iran (Islamic Republic of) 71345-1978 +98 71 3234 1344 akbarzadm@sums.ac.ir Shiraz University of Medical Sciences scientific marzieh akbarzadeh
Namazi Square, Shiraz
shiraz Iran (Islamic Republic of) 71345-1978 +98 71 3425 6647 akbarzadm@sums.ac.ir Shiraz University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria :1) Menopausal women, 2) Women willing to cooperate in this study and presented their written consent form, 3) These women should not suffer from diseases related to liver, kidney, thyroid, parathyroid, intestine and bone…… in which they receive special medicines which affect the bone density, 4)They should not use any kinds of hormonal medicines, 5) Menopausal women who are osteopanic and receive supplementary Calcium and vitamin D, but they do not receive treatment with other with other effective hormonal medicines which affect the bone density (these medicines are mostly used by osteoprose patients), 6) They should not be sensitive to herbal medicines. .Exclusion criteria:1) Allergic reaction to medicine, 2) Detection of a patient, during the study, who needs to use the medicine effective on bone density. no limit no limit Female - - - - Treatment - Drugs Treatment - Drugs Placebo the first intervention group is given, daily, one Agnugol tablets, 3.2- 4.8 Mg for 3 monthes( product Goldarou Company of Esfahan) the second intervention group is given, daily, three Salvigol tablets, 100 Mg for 3 monthes ( product of Goldarou Company of Esfahan) In control group is given each daily three placebo tablets for 3 monthes Osteogenic factors. Timepoint: At the beginning and end of the study. Method of measurement: Blood test. Physical and emotional symptoms. Timepoint: At the beginning and end of the study. Method of measurement: the questionnaire about Menopause Rating Scale(MRS). Vice President of Research Shiraz University of Medical Sciences Approved 2016-01-24 Ethics committee of shiraz university of Medical Sciences Shiraz - Zand Street - Next to the Red Crescent - Sakhtmtn Central University - Class 7 - Research Shiraz Iran (Islamic Republic of)